Explore Products

My Quote Request

No products added yet

6505-01-227-1609

20 Products

ONCOVIN

VINCRISTINE SULFATE INJECTION,USP

NSN, MFG P/N

6505012271609

NSN

6505-01-227-1609

View More Info

ONCOVIN

VINCRISTINE SULFATE INJECTION,USP

NSN, MFG P/N

6505012271609

NSN

6505-01-227-1609

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 2ML SYRINGE 3S
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III SUPPLEMENTARY FEATURES: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
TOTAL PRIMARY CONTAINER QUANTITY: 3

NDC00574-0430-25

PROGESTERONE,USP

NSN, MFG P/N

6505012273559

NSN

6505-01-227-3559

View More Info

NDC00574-0430-25

PROGESTERONE,USP

NSN, MFG P/N

6505012273559

NSN

6505-01-227-3559

MFG

PADDOCK LABORATORIES INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 PERCENTAGE, W/W PROGESTERONE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROGESTERONE USP POWDER FORM 25GM BOTTLE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 GRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: AMBER GLASS BOTTLE

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

View More Info

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 1GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 25

NDC00002-7231-25

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

View More Info

NDC00002-7231-25

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 1GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 25

NDC00173-0378-35

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

View More Info

NDC00173-0378-35

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 1GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 25

TAZIDIME

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

View More Info

TAZIDIME

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505012273570

NSN

6505-01-227-3570

MFG

ELI LILLY AND COMPANY DBA ELI LILLY

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME FOR INJECTION 1GM VIAL 25S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME
TOTAL PRIMARY CONTAINER QUANTITY: 25

5908

SODIUM HYALURONATE INJECTION

NSN, MFG P/N

6505012273598

NSN

6505-01-227-3598

View More Info

5908

SODIUM HYALURONATE INJECTION

NSN, MFG P/N

6505012273598

NSN

6505-01-227-3598

MFG

PRECISION COSMET CO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 0.800 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: IN NORMAL SALINE
TOTAL PRIMARY CONTAINER QUANTITY: 10

AMVISC

SODIUM HYALURONATE INJECTION

NSN, MFG P/N

6505012273598

NSN

6505-01-227-3598

View More Info

AMVISC

SODIUM HYALURONATE INJECTION

NSN, MFG P/N

6505012273598

NSN

6505-01-227-3598

MFG

PRECISION COSMET CO INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
ADMINISTRATION: INTRAOCULAR
FEATURES PROVIDED: STERILE
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 0.800 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: IN NORMAL SALINE
TOTAL PRIMARY CONTAINER QUANTITY: 10

1829-35RX

MULTIVITAMIN FOR INJECTION

NSN, MFG P/N

6505012275004

NSN

6505-01-227-5004

View More Info

1829-35RX

MULTIVITAMIN FOR INJECTION

NSN, MFG P/N

6505012275004

NSN

6505-01-227-5004

MFG

ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 60.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 5.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 10.000 MILLIGRAMS DL-ALPHA-TOCOPHERYL ACETATE
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
PHYSICAL FORM: POWDER,LYOPHILIZED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAIN STABILIZERS; TO BE RECONSTITUTED WITH 5 ML OF STERILE WATER FORINJECTION USP BEFORE ADDING TO IV INFUSION FLUID
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT AND 5.000 MICROGRAMS ERGOCALCIFEROL ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 40.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 4.000 MILLIGRAMS PYRIDOXINE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS RETINOL
~2: ACTIVE INGREDIENT AND 3.600 MILLIGRAMS RIBOFLAVIN PHOSPHATE SODIUM ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT

MVI 12 LYOPHILIZED

MULTIVITAMIN FOR INJECTION

NSN, MFG P/N

6505012275004

NSN

6505-01-227-5004

View More Info

MVI 12 LYOPHILIZED

MULTIVITAMIN FOR INJECTION

NSN, MFG P/N

6505012275004

NSN

6505-01-227-5004

MFG

ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 60.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 5.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 10.000 MILLIGRAMS DL-ALPHA-TOCOPHERYL ACETATE
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
PHYSICAL FORM: POWDER,LYOPHILIZED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAIN STABILIZERS; TO BE RECONSTITUTED WITH 5 ML OF STERILE WATER FORINJECTION USP BEFORE ADDING TO IV INFUSION FLUID
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT AND 5.000 MICROGRAMS ERGOCALCIFEROL ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 40.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 4.000 MILLIGRAMS PYRIDOXINE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS RETINOL
~2: ACTIVE INGREDIENT AND 3.600 MILLIGRAMS RIBOFLAVIN PHOSPHATE SODIUM ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT

NDC00053-1829-35

MULTIVITAMIN FOR INJECTION

NSN, MFG P/N

6505012275004

NSN

6505-01-227-5004

View More Info

NDC00053-1829-35

MULTIVITAMIN FOR INJECTION

NSN, MFG P/N

6505012275004

NSN

6505-01-227-5004

MFG

ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 60.000 MICROGRAMS BIOTIN ACTIVE INGREDIENT AND 5.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT AND 15.000 MILLIGRAMS DEXPANTHENOL ACTIVE INGREDIENT AND 10.000 MILLIGRAMS DL-ALPHA-TOCOPHERYL ACETATE
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: DILUENT AND STERILE
PHYSICAL FORM: POWDER,LYOPHILIZED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAIN STABILIZERS; TO BE RECONSTITUTED WITH 5 ML OF STERILE WATER FORINJECTION USP BEFORE ADDING TO IV INFUSION FLUID
TOTAL PRIMARY CONTAINER QUANTITY: 25
~1: ACTIVE INGREDIENT AND 5.000 MICROGRAMS ERGOCALCIFEROL ACTIVE INGREDIENT AND 400.000 MICROGRAMS FOLIC ACID ACTIVE INGREDIENT AND 40.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 4.000 MILLIGRAMS PYRIDOXINE ACTIVE INGREDIENT AND 1.000 MILLIGRAMS RETINOL
~2: ACTIVE INGREDIENT AND 3.600 MILLIGRAMS RIBOFLAVIN PHOSPHATE SODIUM ACTIVE INGREDIENT AND 3.000 MILLIGRAMS THIAMINE ACTIVE INGREDIENT

NDC00173-0748-35

NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION FOR IRRIGATION,USP

NSN, MFG P/N

6505012275007

NSN

6505-01-227-5007

View More Info

NDC00173-0748-35

NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION FOR IRRIGATION,USP

NSN, MFG P/N

6505012275007

NSN

6505-01-227-5007

MFG

GLAXO WELLCOME INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200000.000 UNITS POLYMYXIN B SULFATE PER MILLILITER AND EQUIVALENT TO 40.000 MG. NEOMYCYCIN PER ML.
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NEOMYCIN AND POLYMYXIN B SULFATES SOLUTION FOR IRRIGATION USP 50S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BURROUGHS WELLCOME CO
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 50

GENAPAP CHILDRENS' CHEWABLE TABS

ACETAMINOPHEN TABLETS,USP

NSN, MFG P/N

6505012275554

NSN

6505-01-227-5554

View More Info

GENAPAP CHILDRENS' CHEWABLE TABS

ACETAMINOPHEN TABLETS,USP

NSN, MFG P/N

6505012275554

NSN

6505-01-227-5554

MFG

GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN TABLETS USP 80MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GENERIX DRUG

NDC00182-1585-17

ACETAMINOPHEN TABLETS,USP

NSN, MFG P/N

6505012275554

NSN

6505-01-227-5554

View More Info

NDC00182-1585-17

ACETAMINOPHEN TABLETS,USP

NSN, MFG P/N

6505012275554

NSN

6505-01-227-5554

MFG

GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACETAMINOPHEN TABLETS USP 80MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,GENERIX DRUG

NDC00008-0200-01

PROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012276721

NSN

6505-01-227-6721

View More Info

NDC00008-0200-01

PROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012276721

NSN

6505-01-227-6721

MFG

AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR;

SPARINE

PROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012276721

NSN

6505-01-227-6721

View More Info

SPARINE

PROMAZINE HYDROCHLORIDE TABLETS,USP

NSN, MFG P/N

6505012276721

NSN

6505-01-227-6721

MFG

AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR;

NDC00004-1962-01

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505012277028

NSN

6505-01-227-7028

View More Info

NDC00004-1962-01

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505012277028

NSN

6505-01-227-7028

MFG

CARDINAL HEALTH 200 LLC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP 250MG VIAL 10S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00409-7337-01

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505012277028

NSN

6505-01-227-7028

View More Info

NDC00409-7337-01

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505012277028

NSN

6505-01-227-7028

MFG

HOSPIRA INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP 250MG VIAL 10S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10

ROCEPHIN

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505012277028

NSN

6505-01-227-7028

View More Info

ROCEPHIN

CEFTRIAXONE SODIUM,USP

NSN, MFG P/N

6505012277028

NSN

6505-01-227-7028

MFG

ROCHE LABORATORIES INC.

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP 250MG VIAL 10S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLIGRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00071-2195-20

DIPHENHYDRAMINE HYDROCHLORIDE SYRUP

NSN, MFG P/N

6505012277332

NSN

6505-01-227-7332

View More Info

NDC00071-2195-20

DIPHENHYDRAMINE HYDROCHLORIDE SYRUP

NSN, MFG P/N

6505012277332

NSN

6505-01-227-7332

MFG

PARKE-DAVIS DIV OF WARNER-LAMBERT CO

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS DIPHENHYDRAMINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: RASPBERRY
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE